Slovakia Pharmaceutical and Medical Goods Expenditure Share (2024)
Slovakia's Pharmaceutical and Medical Goods Expenditure Share: 30 % of current health expenditure in 2024, unchanged YoY.
Slovakia (2024)
30
% of current health expenditure
unchanged YoY
YoY Change
unchanged
percentage points
Trend
neutral
Series length
13
years of data
Data
| Year | % of current health expenditure | YoY Change |
|---|---|---|
| 2024 | 30 | unchanged |
| 2023 | 30 | +0.9pp |
| 2022 | 29.1 | +0.1pp |
| 2021 | 29 | -2.8pp |
| 2020 | 31.8 | -0.2pp |
| 2019 | 32 | -1.4pp |
| 2018 | 33.4 | -1.4pp |
| 2017 | 34.8 | -0.1pp |
| 2016 | 34.9 | -0.4pp |
| 2015 | 35.3 | +0.7pp |
| 2014 | 34.6 | -1.1pp |
| 2013 | 35.7 | unchanged |
| 2012 | 35.7 | n/a |
About this Dataset
Slovakia recorded 30 % of current health expenditure in 2024. That is unchanged on the previous period. Across 2012–2024 the series ranges from 29 % of current health expenditure in 2021 to 35.7 % of current health expenditure in 2013.
This page tracks the share of current health expenditure devoted to pharmaceuticals and medical goods in Slovakia.
Data sourced from Eurostat via SDMX REST API. Values use harmonised methodology intended for cross-country comparison.
Frequently Asked Questions
This page tracks the share of current health expenditure devoted to pharmaceuticals and medical goods in Slovakia. It is published by Eurostat and updated annually.
The most recent observation covers 2024. Eurostat typically publishes this series with a lag of several months after the reference period. The series runs 2012–2024 (13 observations).
The series peaked at 35.7 % of current health expenditure in 2013 and reached its lowest recorded value of 29 % of current health expenditure in 2021. The latest reading is 30 % of current health expenditure in 2024. That is unchanged on the previous period.